A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia

Conditions:   Myelodysplastic Syndromes;   Leukemia, Myeloid, Acute;   Leukemia, Myelomonocytic, Chronic;   Patient Preference Interventions:   Drug: Subcutaneous azacitidine;   Drug: Oral decitabine/cedazuridine Sponsor:   Otsuka Australia Pharmaceutical Pty Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials